MEDIFORD Trademark

Trademark Overview


On Tuesday, December 26, 2023, a trademark application was filed for MEDIFORD with the United States Patent and Trademark Office. The USPTO has given the MEDIFORD trademark a serial number of 98330501. The federal status of this trademark filing is WITHDRAWN BEFORE PUBLICATION as of Thursday, February 27, 2025. This trademark is owned by Mediford Corporation. The MEDIFORD trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; testing and analyzing services of stool, urine and blood being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; clinical testing and analyzing of specimens, namely, blood, bodily fluids, tissues extracted from human and animals for medical diagnostic and treatment purposes provided by medical laboratories; testing and analyzing services of blood and stool for clinical testing for medical diagnostic and treatment purposes provided by medical laboratories; medical analysis of clinical data of clinical trials; medical diagnostic, testing and analyzing services for the diagnosis of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric...

testing, inspection or research on pharmaceuticals, cosmetics, food additives or food including chemicals and agrochemicals for scientific research purposes; testing or research on prevention of pollution for scientific research purposes; testing of drinking water quality for scientific research purposes; environmental measurement and analysis for scientific research purposes; testing of microorganisms for scientific research purposes; environmental hygiene testing and other hygiene testing for scientific research purposes; immunological, biochemical, bacteriological or genetical analysis, testing, inspection or research relating to biological samples for scientific research purposes; analysis, testing, inspection or research relating to bacteriology, genetics or biotechnology for scientific research purposes; testing, inspection or research on agriculture, livestock breeding or fisheries for scientific research purposes; medical testing, inspection or research services for medical res...
mediford

General Information


Serial Number98330501
Word MarkMEDIFORD
Filing DateTuesday, December 26, 2023
Status692 - WITHDRAWN BEFORE PUBLICATION
Status DateThursday, February 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of a dark green polygon to the left of a light green hexagon, both to the left of the word MEDIFORD in gray stylized lettering.
Indication of Colors claimedThe color(s) dark green, light green and gray is/are claimed as a feature of the mark.
Goods and Servicesblood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; testing and analyzing services of stool, urine and blood being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; clinical testing and analyzing of specimens, namely, blood, bodily fluids, tissues extracted from human and animals for medical diagnostic and treatment purposes provided by medical laboratories; testing and analyzing services of blood and stool for clinical testing for medical diagnostic and treatment purposes provided by medical laboratories; medical analysis of clinical data of clinical trials; medical diagnostic, testing and analyzing services for the diagnosis of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, oncological, urological and viral diseases and disorders, blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain, and diabetes; medical diagnostic services for autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, oncological, urological and viral diseases and disorders, blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain, and diabetes; provision of medical information; medical clinical testing and medical evaluation for autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, oncological, urological and viral diseases and disorders, blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain, and diabetes; performing medical diagnosis of diseases based on evaluation of progress of clinical trials for autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, oncological, urological and viral diseases and disorders, blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain, and diabetes; clinical testing, namely, medical testing services; clinical testing for use in medical treatment and medical examination services for human and animals; medical consultancy services relating to clinical tests; medical consultancy services relating to medical care; providing medical advice and information relating to clinical tests; medical and pharmaceutical consultation; medical analysis of clinical data of clinical trials
Goods and Servicestesting, inspection or research on pharmaceuticals, cosmetics, food additives or food including chemicals and agrochemicals for scientific research purposes; testing or research on prevention of pollution for scientific research purposes; testing of drinking water quality for scientific research purposes; environmental measurement and analysis for scientific research purposes; testing of microorganisms for scientific research purposes; environmental hygiene testing and other hygiene testing for scientific research purposes; immunological, biochemical, bacteriological or genetical analysis, testing, inspection or research relating to biological samples for scientific research purposes; analysis, testing, inspection or research relating to bacteriology, genetics or biotechnology for scientific research purposes; testing, inspection or research on agriculture, livestock breeding or fisheries for scientific research purposes; medical testing, inspection or research services for medical research purposes; scientific testing, research or laboratory services for scientific research purposes; providing scientific advice relating to scientific testing, research or laboratory services; scientific research in the nature of conducting clinical trials for others; medical research services, namely, conducting non-clinical trials relating to pharmaceuticals and medical devices; medical testing, inspection, research or development relating to treatment or prevention of diseases for medical research purposes; medical research services; blood testing for scientific research purposes; testing and analyzing services of stool, urine and blood for scientific research purposes; clinical testing and analyzing using specimens such as blood, bodily fluids, tissues extracted from human and animals for scientific research purposes; testing and analyzing services of blood and stool for clinical testing for scientific research purposes; management of clinical data of clinical trials, namely, planning and implementation project management of clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 26, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 26, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMediford Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 174-0053
JP

Trademark Events


Event DateEvent Description
Tuesday, December 26, 2023NEW APPLICATION ENTERED
Monday, April 8, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, April 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 24, 2024ASSIGNED TO EXAMINER
Wednesday, July 31, 2024NON-FINAL ACTION E-MAILED
Wednesday, July 31, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 31, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 10, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, December 10, 2024FINAL REFUSAL E-MAILED
Tuesday, December 10, 2024FINAL REFUSAL WRITTEN
Tuesday, February 4, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 4, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 4, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, February 22, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 27, 2025ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED